Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of fluorinated organic molecules with enhanced metabolic stability and bioavailability. Commonly employed in Suzuki-Miyaura cross-coupling reactions to construct carbon-carbon bonds in drug discovery and medicinal chemistry research. Its protected hydroxyl group allows for selective reactivity, making it valuable in multi-step syntheses where functional group compatibility is critical. Also utilized in the preparation of biologically active compounds, including potential anticancer and anti-inflammatory agents.